Búsqueda | Portal de Búsqueda de la BVS

1.

NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells.

Di Matteo, P; Hackl, C; Jedeszko, C; Valentinis, B; Bordignon, C; Traversari, C; Kerbel, R S; Rizzardi, G-P.

Br J Cancer ; 109(2): 360-9, 2013 Jul 23.

Artículo en Inglés | MEDLINE | ID: mdl-23828516

2.

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours.

Zucali, P A; Simonelli, M; De Vincenzo, F; Lorenzi, E; Perrino, M; Bertossi, M; Finotto, R; Naimo, S; Balzarini, L; Bonifacio, C; Timofeeva, I; Rossoni, G; Mazzola, G; Lambiase, A; Bordignon, C; Santoro, A.

Br J Cancer ; 108(1): 58-63, 2013 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-23169299

3.

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients.

Lorusso, D; Scambia, G; Amadio, G; di Legge, A; Pietragalla, A; De Vincenzo, R; Masciullo, V; Di Stefano, M; Mangili, G; Citterio, G; Mantori, M; Lambiase, A; Bordignon, C.

Br J Cancer ; 107(1): 37-42, 2012 Jun 26.

Artículo en Inglés | MEDLINE | ID: mdl-22644293

4.

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.

Mammoliti, S; Andretta, V; Bennicelli, E; Caprioni, F; Comandini, D; Fornarini, G; Guglielmi, A; Pessino, A; Sciallero, S; Sobrero, A F; Mazzola, G; Lambiase, A; Bordignon, C.

Ann Oncol ; 22(4): 973-978, 2011 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-20855468

5.

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.

Consiglio, A; Quattrini, A; Martino, S; Bensadoun, J C; Dolcetta, D; Trojani, A; Benaglia, G; Marchesini, S; Cestari, V; Oliverio, A; Bordignon, C; Naldini, L.

Nat Med ; 7(3): 310-6, 2001 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-11231629

6.

Progress and prospects: graft-versus-host disease.

Mastaglio, S; Stanghellini, M T L; Bordignon, C; Bondanza, A; Ciceri, F; Bonini, C.

Gene Ther ; 17(11): 1309-17, 2010 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-20508597

7.

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage.

Lupetti, R; Pisarra, P; Verrecchia, A; Farina, C; Nicolini, G; Anichini, A; Bordignon, C; Sensi, M; Parmiani, G; Traversari, C.

J Exp Med ; 188(6): 1005-16, 1998 Sep 21.

Artículo en Inglés | MEDLINE | ID: mdl-9743519

8.

Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer.

Kantoff, P W; Gillio, A P; McLachlin, J R; Bordignon, C; Eglitis, M A; Kernan, N A; Moen, R C; Kohn, D B; Yu, S F; Karson, E.

J Exp Med ; 166(1): 219-34, 1987 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-3298525

9.

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, F G; Caligaris-Cappio, F; Lambiase, A; Bordignon, C.

Br J Cancer ; 103(6): 837-44, 2010 Sep 07.

Artículo en Inglés | MEDLINE | ID: mdl-20717115

10.

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours.

Gregorc, V; Santoro, A; Bennicelli, E; Punt, C J A; Citterio, G; Timmer-Bonte, J N H; Caligaris Cappio, F; Lambiase, A; Bordignon, C; van Herpen, C M L.

Br J Cancer ; 101(2): 219-24, 2009 Jul 21.

Artículo en Inglés | MEDLINE | ID: mdl-19568235

11.

Hematopoietic histoincompatibility reactions by NK cells in vitro: model for genetic resistance to marrow grafts.

Bordignon, C; Daley, J P; Nakamura, I.

Science ; 230(4732): 1398-401, 1985 Dec 20.

Artículo en Inglés | MEDLINE | ID: mdl-3906897

12.

An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.

Ferrari, G; Rossini, S; Giavazzi, R; Maggioni, D; Nobili, N; Soldati, M; Ungers, G; Mavilio, F; Gilboa, E; Bordignon, C.

Science ; 251(4999): 1363-6, 1991 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-1848369

13.

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients.

Bordignon, C; Notarangelo, L D; Nobili, N; Ferrari, G; Casorati, G; Panina, P; Mazzolari, E; Maggioni, D; Rossi, C; Servida, P; Ugazio, A G; Mavilio, F.

Science ; 270(5235): 470-5, 1995 Oct 20.

Artículo en Inglés | MEDLINE | ID: mdl-7570000

14.

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

Bonini, C; Ferrari, G; Verzeletti, S; Servida, P; Zappone, E; Ruggieri, L; Ponzoni, M; Rossini, S; Mavilio, F; Traversari, C; Bordignon, C.

Science ; 276(5319): 1719-24, 1997 Jun 13.

Artículo en Inglés | MEDLINE | ID: mdl-9180086

15.

The challenge of private biomedical research funding in Italy.

Bordignon, C.

Nat Med ; 5(2): 135-7, 1999 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-9930852

16.

A new chance for SCID gene therapy.

Bordignon, C.

Nat Med ; 4(1): 19-20, 1998 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-9427599

17.

Safety of retroviral gene marking with a truncated NGF receptor.

Bonini, C; Grez, M; Traversari, C; Ciceri, F; Marktel, S; Ferrari, G; Dinauer, M; Sadat, M; Aiuti, A; Deola, S; Radrizzani, M; Hagenbeek, A; Apperley, J; Ebeling, S; Martens, A; Kolb, H J; Weber, M; Lotti, F; Grande, A; Weissinger, E; Bueren, J A; Lamana, M; Falkenburg, J H F; Heemskerk, M H M; Austin, T; Kornblau, S; Marini, F; Benati, C; Magnani, Z; Cazzaniga, S; Toma, S; Gallo-Stampino, C; Introna, M; Slavin, S; Greenberg, P D; Bregni, M; Mavilio, F; Bordignon, C.

Nat Med ; 9(4): 367-9, 2003 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-12669036

18.

Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.

Tanzarella, S; Russo, V; Lionello, I; Dalerba, P; Rigatti, D; Bordignon, C; Traversari, C.

Cancer Res ; 59(11): 2668-74, 1999 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-10363990

19.

The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes.

Fleischhauer, K; Gattinoni, L; Dalerba, P; Lauvau, G; Zanaria, E; Dabovic, B; van Endert, P M; Bordignon, C; Traversari, C.

Cancer Res ; 58(14): 2969-72, 1998 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-9679956

20.

Human proinsulin production in primary rat hepatocytes after retroviral vector gene transfer.

Falqui, L; Martinenghi, S; Berra, C; Monti, L; Leone, B E; Pozza, G; Bordignon, C.

J Mol Med (Berl) ; 77(1): 250-3, 1999 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-9930973

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: